Corvus Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2024 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2024 | 3 | -$0.13 | -$0.10 | -$0.12 |
| Q1 2025 | 2 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q3 2025 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
Corvus Pharmaceuticals, Inc. Earnings Date And Information
Corvus Pharmaceuticals, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.11 earnings per share for the quarter, missing analysts' consensus estimates of $-0.11 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Corvus Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-0.56 diluted earnings per share) and currently has a price-to-earnings ratio of -10.5. Corvus Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Corvus Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.11 | -$0.60 | -0.49 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.12 | -$0.07 | 0.05 | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.12 | $0 | |||
| 03/19/2024 | Q4 2023 | -$0.14 | -$0.14 | 0 | $246,000 | |
| 11/07/2023 | Q3 2023 | -$0.16 | -$0.12 | 0.04 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.14 | -$0.14 | 0 | $0 | |
| 05/08/2023 | Q1 2023 | -$0.16 | -$0.19 | -0.03 | $0 | |
| 03/28/2023 | Q4 2022 | -$0.35 | $0 | |||
| 11/03/2022 | Q3 2022 | -$0.16 | -$0.32 | -0.16 | $0 | |
| 08/08/2022 | Q2 2022 | -$0.19 | -$0.18 | 0.01 | $0 | |
| 05/05/2022 | Q1 2022 | -$0.14 | -$0.20 | -0.06 | $0 | |
| 03/10/2022 | Q4 2021 | -$0.20 | -$0.20 | 0 | $0 | |
| 11/01/2021 | Q3 2021 | -$0.30 | -$0.24 | 0.06 | $0 | |
| 08/02/2021 | Q2 2021 | -$0.32 | -$0.28 | 0.04 | $0 | |
| 04/29/2021 | Q1 2021 | -$0.33 | -$0.34 | -0.01 | $0 | |
| 03/25/2021 | Q4 2020 | -$0.32 | $0.92 | 1.24 | $0 | |
| 10/29/2020 | Q3 2020 | -$0.25 | -$0.33 | -0.08 | $0 | |
| 07/30/2020 | Q2 2020 | -$0.30 | -$0.36 | -0.06 | $0 | |
| 04/30/2020 | Q1 2020 | -$0.40 | -$0.44 | -0.04 | $0 | |
| 03/09/2020 | Q4 2019 | -$0.38 | $0 |
Corvus Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Corvus Pharmaceuticals, Inc.'s earnings date?
Corvus Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
-
How can I listen to Corvus Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Corvus Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Corvus Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Corvus Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Corvus Pharmaceuticals, Inc. generate each year?
Corvus Pharmaceuticals, Inc. (:CRVS) has a recorded net income of $0. Corvus Pharmaceuticals, Inc. has generated $-0.56 earnings per share over the last four quarters.
-
What is Corvus Pharmaceuticals, Inc.'s price-to-earnings ratio?
Corvus Pharmaceuticals, Inc. (:CRVS) has a price-to-earnings ratio of -10.5 and price/earnings-to-growth ratio is 0.1.
